Cite
Genome-scale CRISPR-Cas9 knockout screening in gastrointestinal stromal tumor with Imatinib resistance.
MLA
Cao, Jie, et al. “Genome-Scale CRISPR-Cas9 Knockout Screening in Gastrointestinal Stromal Tumor with Imatinib Resistance.” Molecular Cancer, vol. 17, no. 1, Aug. 2018, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s12943-018-0865-2.
APA
Cao, J., Wei, J., Yang, P., Zhang, T., Chen, Z., He, F., Wei, F., Chen, H., Hu, H., Zhong, J., Yang, Z., Cai, W., Li, W., & Wang, Q. (2018). Genome-scale CRISPR-Cas9 knockout screening in gastrointestinal stromal tumor with Imatinib resistance. Molecular Cancer, 17(1), N.PAG. https://doi.org/10.1186/s12943-018-0865-2
Chicago
Cao, Jie, Jianchang Wei, Ping Yang, Tong Zhang, Zhuanpeng Chen, Feng He, Fang Wei, et al. 2018. “Genome-Scale CRISPR-Cas9 Knockout Screening in Gastrointestinal Stromal Tumor with Imatinib Resistance.” Molecular Cancer 17 (1): N.PAG. doi:10.1186/s12943-018-0865-2.